Medication Safety

Safe management of therapeutic drug monitoring

17 October 2024Organisations must ensure safe management systems are in place to support the management of drugs requiring therapeutic drug monitoring.

Assessing injectables for enteral administration

2 January 2026Clinical decisions on the use of injectable formulations for enteral administration should be guided by safety and practicality.

Defining time critical medicines

18 December 2025A resource to support healthcare professionals in defining time critical medicines to support safety improvements.

Understanding design for safety in medicines packaging and labels

17 December 2025Understanding principles and limitations of good design can support the safer use of medicines. Consideration of these principles in practice can reduce harms.

Ensuring the safe use of amphotericin B injection

25 November 2025Amphotericin B liposomal products and Fungizone are not interchangeable. Take action to prevent death caused by inadvertent mis-selection

Safer use of time critical medicines programme

6 May 2026An update on the programme's progress, including the quality improvement collaborative, wider community of practice and related outputs.

Safety considerations when switching insulin products

6 May 2026Healthcare professionals should be aware of the risks and safe practice principles when switching insulin products.

Product Risk Assessment Tools

15 March 2016Product risk assessment tools to support NHS organisations to identify risk resultant from medicinal product presentation.

Worked example of assessing the risk of transcribing

28 January 2025Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.

Safety considerations when using Vitamin D

22 March 2024Healthcare professionals who use vitamin D should be aware of the risks of toxicity and safe practice principles which may prevent patient harm